@misc{10902/13761,
editor = {Organización Mundial de la Propiedad Intelectual (OMPI/WIPO)},
year = {2017},
url = {http://hdl.handle.net/10902/13761},
abstract = {ABSTRACT: The present invention relates to the use of allelic variants of human TLR10, including the allelic variant of human TLR10, I473T, as biomarkers for predicting gravity or prognosis in inflammatory diseases, including rheumatoid arthritis, and/or for predicting the response to a treatment using anti-inflammatory agents such as anti-TNFα agents.},
abstract = {RESUMEN: La presente invención se refiere al uso de variantes alélicas de TLR10 humano, incluyendo a la variante alélica de TLR10 humano I473T: como biomarcador para predecir la gravedad o el pronóstico en enfermedades inflamatorias, incluyendo la artritis reumatoide y/o para predecir la respuesta a un tratamiento con agentes antiinflamatorios, tales como agentes anti-TNFα.},
title = {Method for predicting the clinical response to a treatment with anti-inflammatory agents},
author = {Fernández Luna, José Luis and Martínez Taboada, Víctor Manuel and López Hoyos, Marcos and Torices del Val, Silvia and Muñoz Cacho, Pedro and Varela Egocheaga, Ignacio and Balsa Criado, Alejandro and Marsal Barril, Sara and Juliá Cano, Antonio},
}